Search

everythinglearnresearchcommunity

for

Search:↓

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

ATX-101 injections can cause hair loss.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

Finasteride may increase suicide risk; more research needed.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Tioconazole cream is highly effective and easy to use for treating sheep dermatophytosis.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Male pattern baldness may predict prostate cancer risk.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Some birth control pills have a higher risk of blood clots than others.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.